121 related articles for article (PubMed ID: 16803494)
1. Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study.
Pieterse QD; Trimbos JB; Dijkman A; Creutzberg CL; Gaarenstroom KN; Peters AA; Kenter GG
Int J Gynecol Cancer; 2006; 16(3):1112-8. PubMed ID: 16803494
[TBL] [Abstract][Full Text] [Related]
2. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
3. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.
Rushdan MN; Tay EH; Khoo-Tan HS; Lee KM; Low JH; Ho TH; Yam KL
Ann Acad Med Singap; 2004 Jul; 33(4):467-72. PubMed ID: 15329758
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
6. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria.
Chang SJ; Kim WY; Yoo SC; Yoon JH; Chun M; Chang KH; Ryu HS
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):91-6. PubMed ID: 19695765
[TBL] [Abstract][Full Text] [Related]
7. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
Yessaian A; Magistris A; Burger RA; Monk BJ
Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
[TBL] [Abstract][Full Text] [Related]
8. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
9. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
11. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors.
Atahan IL; Yildiz F; Ozyar E; Pehlivan B; Genc M; Kose MF; Tulunay G; Ayhan A; Yuce K; Guler N; Kucukali T
Int J Gynecol Cancer; 2007; 17(4):813-20. PubMed ID: 17359296
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Assessment of morbidity and recurrences.
Frigerio L; Busci L; Rabaiotti E; Mariani A
Eur J Gynaecol Oncol; 1994; 15(2):132-7. PubMed ID: 8005143
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
16. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
17. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix.
van der Velden J; Samlal R; Schilthuis MS; Gonzalez DG; ten Kate FJ; Lammes FB
Gynecol Oncol; 1999 Nov; 75(2):233-7. PubMed ID: 10525378
[TBL] [Abstract][Full Text] [Related]
18. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
